Eventide Asset Management - Q1 2018 holdings

$2.14 Billion is the total value of Eventide Asset Management's 144 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 18.6% .

 Value Shares↓ Weighting
ASND  ASCENDIS PHARMA A Ssponsored adr$87,148,000
+63.3%
1,332,5400.0%4.08%
+46.6%
XPO  XPO LOGISTICS INC$80,226,000
+11.2%
788,0000.0%3.76%
-0.2%
COLL  COLLEGIUM PHARMACEUTICAL INC$56,404,000
+38.4%
2,207,6100.0%2.64%
+24.3%
AVXS  AVEXIS INC$52,027,000
+11.7%
421,0000.0%2.44%
+0.3%
AIMT BuyAIMMUNE THERAPEUTICS INC$49,813,000
+7.4%
1,564,983
+27.6%
2.33%
-3.5%
LOW  LOWES COS INC$49,579,000
-5.6%
565,0000.0%2.32%
-15.2%
BLUE  BLUEBIRD BIO INC$47,401,000
-4.1%
277,6030.0%2.22%
-13.9%
LRCX  LAM RESEARCH CORP$46,117,000
+10.4%
227,0000.0%2.16%
-0.9%
SPLK BuySPLUNK INC$44,571,000
+62.5%
453,000
+36.9%
2.09%
+46.0%
ABBV  ABBVIE INC$42,309,000
-2.1%
447,0000.0%1.98%
-12.1%
W  WAYFAIR INCcl a$42,274,000
-15.9%
626,0000.0%1.98%
-24.4%
SAGE BuySAGE THERAPEUTICS INC$40,268,000
+32.4%
250,000
+35.4%
1.88%
+18.9%
INST BuyINSTRUCTURE INC$39,705,000
+42.5%
942,000
+11.9%
1.86%
+27.9%
VRTX BuyVERTEX PHARMACEUTICALS INC$39,604,000
+46.8%
243,000
+35.0%
1.85%
+31.9%
MIC BuyMACQUARIE INFRASTRUCTURE COR$38,112,000
-19.5%
1,032,000
+40.0%
1.78%
-27.7%
HUBS BuyHUBSPOT INC$37,905,000
+106.2%
350,000
+68.3%
1.78%
+85.1%
WCN  WASTE CONNECTIONS INC$37,090,000
+1.1%
517,0000.0%1.74%
-9.2%
MGA BuyMAGNA INTL INC$34,852,000
+0.8%
618,500
+1.4%
1.63%
-9.4%
LEA  LEAR CORP$34,241,000
+5.3%
184,0000.0%1.60%
-5.4%
WBC  WABCO HLDGS INC$34,217,000
-6.7%
255,6000.0%1.60%
-16.2%
ASML  ASML HOLDING N V$34,152,000
+14.2%
172,0000.0%1.60%
+2.6%
CCI  CROWN CASTLE INTL CORP NEW$33,431,000
-1.3%
305,0000.0%1.56%
-11.3%
STLD SellSTEEL DYNAMICS INC$33,342,000
-11.2%
754,000
-13.4%
1.56%
-20.3%
KAR  KAR AUCTION SVCS INC$33,062,000
+7.3%
610,0000.0%1.55%
-3.6%
CELG BuyCELGENE CORP$32,205,000
+12.5%
361,000
+31.6%
1.51%
+1.1%
NEP BuyNEXTERA ENERGY PARTNERS LP$32,080,000
-4.9%
802,200
+2.5%
1.50%
-14.6%
STKL BuySUNOPTA INC$30,534,000
+1.0%
4,300,540
+10.2%
1.43%
-9.3%
SGEN BuySEATTLE GENETICS INC$29,153,000
+3.8%
557,000
+6.1%
1.36%
-6.8%
VRNS BuyVARONIS SYS INC$28,980,000
+255.3%
479,000
+185.1%
1.36%
+219.3%
FIVN BuyFIVE9 INC$26,632,000
+85.8%
894,000
+55.2%
1.25%
+66.9%
LOXO SellLOXO ONCOLOGY INC$26,420,000
+10.1%
229,000
-19.6%
1.24%
-1.1%
IDTI  INTEGRATED DEVICE TECHNOLOGY$25,243,000
+2.8%
826,0000.0%1.18%
-7.7%
GTTN BuyGTT COMMUNICATIONS INC$25,005,000
+1161.0%
441,000
+943.9%
1.17%
+1036.9%
SNA BuySNAP ON INC$24,266,000
-15.3%
164,470
+0.1%
1.14%
-23.9%
LII BuyLENNOX INTL INC$24,116,000
+54.4%
118,000
+57.3%
1.13%
+38.7%
ARW  ARROW ELECTRS INC$22,721,000
-4.2%
295,0000.0%1.06%
-14.0%
ELLI  ELLIE MAE INC$22,249,000
+2.8%
242,0000.0%1.04%
-7.6%
XLRN SellACCELERON PHARMA INC$20,719,000
-25.3%
529,900
-19.0%
0.97%
-33.0%
JELD BuyJELD-WEN HLDG INC$19,722,000
-1.1%
644,100
+27.2%
0.92%
-11.2%
PANW BuyPALO ALTO NETWORKS INC$18,878,000
+44.7%
104,000
+15.6%
0.88%
+30.0%
CAFD Buy8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt$18,876,000
-15.1%
1,553,600
+6.3%
0.88%
-23.7%
ONCE SellSPARK THERAPEUTICS INC$17,979,000
+7.9%
270,000
-16.7%
0.84%
-3.0%
PFPT  PROOFPOINT INC$17,957,000
+28.0%
158,0000.0%0.84%
+15.0%
PEGI BuyPATTERN ENERGY GROUP INCcl a$17,887,000
-18.8%
1,034,500
+1.0%
0.84%
-27.1%
TTD SellTHE TRADE DESK INC$17,863,000
-43.3%
360,000
-47.8%
0.84%
-49.1%
ANET NewARISTA NETWORKS INC$16,850,00066,000
+100.0%
0.79%
SRPT BuySAREPTA THERAPEUTICS INC$16,744,000
+86.9%
226,000
+40.4%
0.78%
+67.9%
IPHI  INPHI CORP$16,706,000
-17.8%
555,0000.0%0.78%
-26.2%
APTV BuyAPTIV PLC$16,697,000
+24.6%
196,500
+24.4%
0.78%
+11.9%
STML  STEMLINE THERAPEUTICS INC$16,622,000
-1.9%
1,086,4000.0%0.78%
-11.9%
ROP NewROPER TECHNOLOGIES INC$16,561,00059,000
+100.0%
0.78%
AY BuyATLANTICA YIELD PLC$16,202,000
-5.2%
827,500
+2.7%
0.76%
-14.8%
WVE SellWAVE LIFE SCIENCES LTD$15,158,000
-0.4%
378,000
-12.8%
0.71%
-10.5%
CRUS  CIRRUS LOGIC INC$15,033,000
-21.7%
370,0000.0%0.70%
-29.6%
AGIO SellAGIOS PHARMACEUTICALS INC$14,557,000
+19.0%
178,000
-16.8%
0.68%
+6.9%
HASI BuyHANNON ARMSTRONG SUST INFR C$14,118,000
-15.8%
724,000
+3.8%
0.66%
-24.4%
BPMC  BLUEPRINT MEDICINES CORP$13,755,000
+21.6%
150,0000.0%0.64%
+9.2%
VYGR  VOYAGER THERAPEUTICS INC$13,217,000
+13.2%
703,4250.0%0.62%
+1.6%
NBIX  NEUROCRINE BIOSCIENCES INC$12,937,000
+6.9%
156,0000.0%0.61%
-4.0%
VMC  VULCAN MATLS CO$12,559,000
-11.1%
110,0000.0%0.59%
-20.1%
TWLO SellTWILIO INCcl a$12,485,000
-8.0%
327,000
-43.1%
0.58%
-17.3%
MYOV BuyMYOVANT SCIENCES LTD$12,199,000
+74.8%
573,553
+3.9%
0.57%
+56.9%
VCYT  VERACYTE INC$11,862,000
-14.9%
2,133,5000.0%0.56%
-23.6%
ZGNX BuyZOGENIX INC$10,613,000
+57.7%
265,000
+57.7%
0.50%
+41.6%
DOOR  MASONITE INTL CORP NEW$10,430,000
-17.3%
170,0000.0%0.49%
-25.7%
PAYC BuyPAYCOM SOFTWARE INC$10,309,000
+598.0%
96,000
+422.3%
0.48%
+527.3%
FENC  FENNEC PHARMACEUTICALS INC$8,961,000
+21.3%
741,1750.0%0.42%
+9.1%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$8,913,000
+36.5%
346,000
+43.0%
0.42%
+22.6%
KALV BuyKALVISTA PHARMACEUTICALS INC$8,532,000
+23.4%
900,000
+26.9%
0.40%
+10.8%
BOLD BuyAUDENTES THERAPEUTICS INC$8,114,000
+15.4%
270,000
+20.0%
0.38%
+3.5%
ARGX NewARGENX SEsponsored adr$8,044,000100,000
+100.0%
0.38%
TSLA  TESLA INC$7,984,000
-14.5%
30,0000.0%0.37%
-23.2%
IFRX  INFLARX NV$7,931,000
+37.7%
275,0000.0%0.37%
+23.7%
REGN BuyREGENERON PHARMACEUTICALS$7,920,000
+180.9%
23,000
+206.7%
0.37%
+152.4%
QURE NewUNIQURE NV$7,873,000335,000
+100.0%
0.37%
MYOK BuyMYOKARDIA INC$7,418,000
+60.2%
152,000
+38.2%
0.35%
+44.0%
RCKT NewROCKET PHARMACEUTICALS INC$7,398,000394,585
+100.0%
0.35%
ALNY SellALNYLAM PHARMACEUTICALS INC$7,384,000
-35.4%
62,000
-31.1%
0.35%
-41.9%
MNTA NewMOMENTA PHARMACEUTICALS INC$7,260,000400,000
+100.0%
0.34%
EXR BuyEXTRA SPACE STORAGE INC$7,251,000
+1.1%
83,000
+1.2%
0.34%
-9.4%
GWPH  GW PHARMACEUTICALS PLCads$7,155,000
-14.6%
63,5000.0%0.34%
-23.3%
XNCR SellXENCOR INC$6,835,000
-0.4%
228,000
-27.2%
0.32%
-10.6%
VBIV  VBI VACCINES INC$6,475,000
-18.0%
1,850,0000.0%0.30%
-26.5%
CERN  CERNER CORP$6,276,000
-13.9%
108,2000.0%0.29%
-22.6%
SNSS  SUNESIS PHARMACEUTICALS INC$6,162,000
-26.3%
2,265,4550.0%0.29%
-33.9%
BMRN  BIOMARIN PHARMACEUTICAL INC$6,080,000
-9.1%
75,0000.0%0.28%
-18.3%
SUPN  SUPERNUS PHARMACEUTICALS INC$5,954,000
+14.9%
130,0000.0%0.28%
+3.3%
ATHN  ATHENAHEALTH INC$5,292,000
+7.5%
37,0000.0%0.25%
-3.5%
EXAS BuyEXACT SCIENCES CORP$5,283,000
+0.6%
131,000
+31.0%
0.25%
-9.9%
AKCA SellAKCEA THERAPEUTICS INC$4,482,000
-38.5%
175,000
-58.3%
0.21%
-44.7%
RARE  ULTRAGENYX PHARMACEUTICAL IN$4,457,000
+9.9%
87,4000.0%0.21%
-0.9%
GLPG SellGALAPAGOS NVspon adr$3,990,000
-18.2%
40,000
-23.1%
0.19%
-26.4%
RGEN  REPLIGEN CORP$3,980,000
-0.3%
110,0000.0%0.19%
-10.6%
DBVT  DBV TECHNOLOGIES S Asponsored adr$3,922,000
-6.2%
170,0000.0%0.18%
-15.6%
MGNX  MACROGENICS INC$3,699,000
+32.4%
147,0000.0%0.17%
+18.5%
ECYT NewENDOCYTE INC$3,182,000350,000
+100.0%
0.15%
BEP BuyBROOKFIELD RENEWABLE PARTNERpartnership unit$3,082,000
+13.5%
99,000
+27.2%
0.14%
+1.4%
SLDB NewSOLID BIOSCIENCES INC$3,000,000400,000
+100.0%
0.14%
IRWD  IRONWOOD PHARMACEUTICALS INC$2,963,000
+3.0%
192,0000.0%0.14%
-7.3%
MDGL NewMADRIGAL PHARMACEUTICALS INC$2,920,00025,000
+100.0%
0.14%
DERM BuyDERMIRA INC$2,669,000
-22.6%
334,000
+169.4%
0.12%
-30.6%
INCY BuyINCYTE CORP$2,583,000
+1.0%
31,000
+14.8%
0.12%
-9.0%
ACAD SellACADIA PHARMACEUTICALS INC$2,553,000
-74.7%
113,600
-66.1%
0.12%
-77.1%
DLPH  DELPHI TECHNOLOGIES PLC$2,510,000
-9.2%
52,6660.0%0.12%
-18.1%
VICL  VICAL INC$2,465,000
-20.8%
1,700,0000.0%0.12%
-29.0%
FHB BuyFIRST HAWAIIAN INC$2,463,000
+15.5%
88,500
+21.1%
0.12%
+3.6%
ACRS  ACLARIS THERAPEUTICS INC$2,453,000
-28.9%
140,0000.0%0.12%
-36.1%
AQXP  AQUINOX PHARMACEUTICALS INC$2,464,000
+19.7%
175,0000.0%0.12%
+7.5%
JCI BuyJOHNSON CTLS INTL PLC$2,343,000
+17.1%
66,500
+26.7%
0.11%
+5.8%
ABB BuyABB LTDsponsored adr$2,255,000
+11.6%
95,000
+26.2%
0.11%
+1.0%
HMC BuyHONDA MOTOR LTD$2,049,000
+10.6%
59,000
+8.6%
0.10%
-1.0%
RARX NewRA PHARMACEUTICALS INC$2,060,000388,000
+100.0%
0.10%
SYRS  SYROS PHARMACEUTICALS INC$1,947,000
+33.4%
150,0000.0%0.09%
+19.7%
SEP SellSPECTRA ENERGY PARTNERS LP$1,850,000
-25.1%
55,000
-12.0%
0.09%
-32.6%
PTCT  PTC THERAPEUTICS INC$1,845,000
+62.1%
68,2000.0%0.09%
+45.8%
BuyESSA PHARMA INC$1,831,000
+217.9%
9,639,410
+254.5%
0.09%
+186.7%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored adr$1,816,000
+18.9%
41,500
+7.8%
0.08%
+6.2%
FPRX SellFIVE PRIME THERAPEUTICS INC$1,804,000
-73.9%
105,000
-66.7%
0.08%
-76.7%
TERP NewTERRAFORM PWR INC$1,728,000161,000
+100.0%
0.08%
BDN BuyBRANDYWINE RLTY TRsh ben int new$1,644,000
+10.9%
103,500
+27.0%
0.08%0.0%
BG BuyBUNGE LIMITED$1,604,000
+30.6%
21,700
+18.6%
0.08%
+17.2%
TSRO  TESARO INC$1,486,000
-31.0%
26,0000.0%0.07%
-37.5%
PRTA SellPROTHENA CORP PLC$1,358,000
-69.8%
37,000
-69.2%
0.06%
-72.8%
TNDM NewTANDEM DIABETES CARE INC$1,364,000275,000
+100.0%
0.06%
ETN BuyEATON CORP PLC$1,358,000
+35.4%
17,000
+33.9%
0.06%
+23.1%
MLHR BuyMILLER HERMAN INC$1,304,000
+2.7%
40,800
+28.7%
0.06%
-7.6%
APU BuyAMERIGAS PARTNERS L Punit l p int$1,279,000
+10.6%
32,000
+28.0%
0.06%0.0%
 HANNON ARMSTRONG SUST INFR Cnote 4.125% 9/0$1,198,000
-7.1%
1,250,0000.0%0.06%
-16.4%
CCIPRA BuyCROWN CASTLE INTL CORP NEW6.875% con pfd a$1,115,000
+30.9%
990
+31.1%
0.05%
+18.2%
CVA BuyCOVANTA HLDG CORP$1,066,000
+54.9%
73,500
+80.6%
0.05%
+38.9%
NYLD BuyNRG YIELD INCcl c$1,037,000
+75.2%
61,000
+94.9%
0.05%
+58.1%
WELL BuyWELLTOWER INC$958,000
+69.9%
17,600
+98.9%
0.04%
+55.2%
VTR BuyVENTAS INC$966,000
+62.6%
19,500
+97.0%
0.04%
+45.2%
MNLO NewMENLO THERAPEUTICS INC$940,00025,000
+100.0%
0.04%
GPMT NewGRANITE PT MTG TR INC$918,00055,500
+100.0%
0.04%
WBK BuyWESTPAC BKG CORPsponsored adr$887,000
+6.7%
40,000
+17.3%
0.04%
-2.3%
CIG BuyCOMPANHIA ENERGETICA DE MINAsp adr n-v pfd$864,000
+42.1%
335,000
+13.6%
0.04%
+25.0%
ERIC BuyERICSSONadr b sek 10$736,000
+15.9%
115,000
+21.1%
0.03%
+3.0%
LPT BuyLIBERTY PPTY TRsh ben int$616,000
+19.4%
15,500
+29.2%
0.03%
+7.4%
EIGR SellEIGER BIOPHARMACEUTICALS INC$621,000
-64.4%
63,000
-49.6%
0.03%
-68.1%
LXP BuyLEXINGTON REALTY TRUST$630,000
+18.6%
80,000
+45.5%
0.03%
+3.6%
AYI BuyACUITY BRANDS INC$564,000
-2.9%
4,050
+22.7%
0.03%
-13.3%
 ACORDA THERAPEUTICS INCnote 1.750% 6/1$366,000
+7.3%
400,0000.0%0.02%
-5.6%
NewHERCULES CAPITAL INCdbcv 4.375% 2/0$203,000200,000
+100.0%
0.01%
CMTA ExitCLEMENTIA PHARMACEUTICALS IN$0-60,000
-100.0%
-0.06%
CDTX ExitCIDARA THERAPEUTICS INC$0-172,000
-100.0%
-0.06%
TERP ExitTERRAFORM PWR INC$0-103,300
-100.0%
-0.06%
BCRX ExitBIOCRYST PHARMACEUTICALS$0-290,000
-100.0%
-0.07%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-20,000
-100.0%
-0.10%
ACHN ExitACHILLION PHARMACEUTICALS IN$0-850,000
-100.0%
-0.13%
NTUS ExitNATUS MEDICAL INC DEL$0-75,000
-100.0%
-0.15%
TTPH ExitTETRAPHASE PHARMACEUTICALS I$0-463,700
-100.0%
-0.15%
TCON ExitTRACON PHARMACEUTICALS INC$0-900,000
-100.0%
-0.16%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-275,000
-100.0%
-0.30%
SAGE ExitSAGE THERAPEUTICS INCcall$0-100,000
-100.0%
-0.86%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2018-05-18
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q1 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Eventide Asset Management's holdings